Shaked Lab

Technion - Israel Institute of Technology

- · Israel

ERC-funded
Rate this labNo reviews yet — be the first.

Research focus

ERC Consolidator Grant · 2017

Phenotype switching: plasticity and/or differentiation of stromal cells and their progenitors within the tumour microenvironment regulate tumour fate.

The limited success of cancer therapy especially in advanced metastatic disease warrants a reassessment, especially given our limited understanding of the nature of cancer cells and the factors that allow them to proliferate and metastasise. Stromal cells of the tumour microenvironment, including fibroblasts, endothelial, immune, adipose and mesenchymal cells, significantly affect cancer cell characteristics and tumour fate; however, their sometimes dichotomous function in high- and low-aggressive tumours has not been thoroughly investigated. Here, we propose to elucidate the largely unknown role of haematopoietic stem and/or progenitor cells (HSCs) on tumour growth and metastases. We found…

From the public funding record at EU CORDIS. Describes the funded project, not the reviews below.

Reviews

← All labs at Technion - Israel Institute of Technology